Security key
483119103
- Security type / class
- Equity / Stock
- Total 13F shares
- 36,936,044
- Total 13F value
- $248,937,960
- Share change
- -287,364
- Put/Call ratio
- 238%
- SEC-reported price per share
- $6.74
- Number of holders
- 116
- Value change
- -$1,972,295
- Number of buys
- 46
- Number of sells
- 57
Open additional details 1 more signal available
Report period
Q1 2021
Institutions
116
Top holders
10
KALA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
KALA BIO, Inc. SEC filings
KALA BIO, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 483119103
Recent filing periods:
Ownership snapshot
Top reported holders of KALA - KALA BIO INC COM - Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F
Highest disclosed value: $73,730,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $73.73M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value
Top 5
RA CAPITAL MANAGEMENT, L.P.
$73.73M
ORBIMED ADVISORS LLC
$37.05M
EVENTIDE ASSET MANAGEMENT, LLC
$23.39M
BlackRock Finance, Inc.
$21.43M
VANGUARD GROUP INC
$13.1M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
—
denominator unverified
|
$73,730,000
10,874,613 shares
|
— | 31 Dec 2020 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$37,053,000
5,465,030 shares
|
— | 31 Dec 2020 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$23,391,000
3,450,000 shares
|
— | 31 Dec 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$21,429,000
3,160,506 shares
|
— | 31 Dec 2020 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$13,105,000
1,932,850 shares
|
— | 31 Dec 2020 |
| CAXTON CORP |
13F
Company
|
—
denominator unverified
|
$7,745,000
1,142,360 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
116
Shares
36,936,044
Rows available
116
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q1 2026 Across Filers
Q1 2026 holders
2
Q1 2021 holders
116
Holder diff
114
| Investor | Q1 2026 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend